Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole and Topiramate on Free-Choice Alcohol Use
NCT00884884Phase 3Completed
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Sep 2007
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aripiprazole and topiramate in alcohol dependence (9 arms), sponsored by National Institute on Alcohol Abuse and Alcoholism. Primary endpoints: Number of alcoholic drinks consumed in a laboratory setting at 90 minutes and Safety and tolerability of the medications singly and in combination at 4 years. Started Sep 2007; status: completed.
02
Drugs
aripiprazoletopiramate
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00884884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00884884.